About Kaliberr Labs Private Limited
Data last updated:
Kaliberr Labs Private Limited is a private limited company based in Malegaon, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2016PTC284717. Its GSTIN is 05AAGCK5842B1ZU (Uttarakhand).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Madhusudan Ramratan Bhandari and Sushant Madhusudan Bhandari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S.No. 12/1 Plot No. 23 Tipre Colony Camp Road, Malegaon, Maharashtra, India – 423203.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.07 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹85,957 (net margin -8.5%) and EBITDA of ₹44,161 (EBITDA margin 4.4%). Revenue has declined at a compounded annual rate (CAGR) of 76% over three years and 57% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kaliberrlabs.com.
Company details
Contact details
Kaliberr Labs Private Limited's registered office is in Malegaon, Maharashtra. Its website is kaliberrlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressS.No. 12/1 Plot No. 23 Tipre Colony Camp Road, Malegaon, Maharashtra, India – 423203
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kaliberr Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Kaliberr Labs Private Limited
FY 2025 filings availableKaliberr Labs Private Limited reported revenue of ₹10.07 Lakh (down 98% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 57% over five years, including a 98% fall in the latest year. EBITDA fell 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44,161 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹85,957 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | ||||
| Net Profit Margin | -8.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kaliberr Labs Private Limited, buy the company report.
Board of directors of Kaliberr Labs Private Limited
Kaliberr Labs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhusudan Ramratan Bhandari Also directs: Kaliberr Bioscience Private Limited | Director | 11 Aug 2016 | 10 Years 2 Months | Current |
| Sushant Madhusudan Bhandari Also directs: Kaliberr Bioscience Private Limited | Director | 11 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Kaliberr Labs Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Archaea Pharma (India) Private Limited | ₹10.08 Lakh (FY 2024) | 75.0% | Ghaziabad, Uttar Pradesh, India | |||
| Kaliberr Labs Private Limitedthis company | ₹10.07 Lakh (FY 2024) | -₹85,957 | -8.5% | -98.0% | Malegaon, Maharashtra, India | |
| Norwest Pharmaceuticals Private Limited | ₹9.95 Lakh (FY 2025) | 25.0% | New Delhi, Delhi, India | |||
| Niharith Pharma Private Limited | ₹9.9 Lakh (FY 2020) | Dehradun, Uttarakhand, India | ||||
| Nutrileno Pharmaceutical Private Limited | ₹9.89 Lakh (FY 2025) | 37.0% | Poothole P O, Kerala, India |
To see the full peer comparison of Kaliberr Labs Private Limited, buy the company report.
Auditor
Kaliberr Labs Private Limited is audited by UPENDRA MEHTA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| UPENDRA MEHTA & ASSOCIATES | FY 2023 | 107393W |
Shareholding
The shareholding of Kaliberr Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kaliberr Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kaliberr Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kaliberr Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kaliberr Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAGCK5842B1ZU | Uttarakhand | Active | 04 May 2018 |
To see the full GST registrations and return filing status of Kaliberr Labs Private Limited, buy the company report.
Recent activity
Kaliberr Labs Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Madhusudan Ramratan Bhandari was appointed as Director on 11 Aug 2016.
Frequently asked questions
Kaliberr Labs is an active private limited company based in Malegaon, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 August 2016 (10+ years old) and is registered under CIN U24230MH2016PTC284717.
Kaliberr Labs has 2 current directors:
- Madhusudan Ramratan Bhandari - Director
- Sushant Madhusudan Bhandari - Director
The latest financial statements of Kaliberr Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Kaliberr Labs is 05AAGCK5842B1ZU, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Kaliberr Labs is U24230MH2016PTC284717. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kaliberr Labs was incorporated on 11 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Kaliberr Labs by revenue are Archaea Pharma (India) Private Limited, Norwest Pharmaceuticals Private Limited, Niharith Pharma Private Limited, Nutrileno Pharmaceutical Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Madhusudan Ramratan Bhandari was appointed as Director on 11 Aug 2016. Sushant Madhusudan Bhandari was appointed as Director on 11 Aug 2016.
Kaliberr Labs can be reached through the website kaliberrlabs.com. Its registered office is in Malegaon, Maharashtra, India.
The registered office of Kaliberr Labs is at S.No. 121 Plot No. 23 Tipre Colony Camp Road, Malegaon, Maharashtra, India – 423203.
Kaliberr Labs operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
